Corbus Pharmaceuticals Holdings (CRBP) Other Non-Current Assets (2014 - 2025)

Corbus Pharmaceuticals Holdings' Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $1.8 million for Q4 2025.

• On a quarterly basis, Other Non-Current Assets rose 368.83% year-over-year to $1.8 million in Q4 2025; TTM through Dec 2025 was $1.8 million, a 368.83% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, up 368.83% from the prior year.
• Other Non-Current Assets advanced to $1.8 million in Q4 2025 per CRBP's latest filing, from $385000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $1.8 million in Q4 2025 and bottomed at $2614.0 in Q2 2021.
• The 5-year median for Other Non-Current Assets is $385000.0 (2024), against an average of $447826.7.
• Across the five-year window, Other Non-Current Assets plunged 93.08% in 2021 and jumped 18164.15% in 2022, its largest moves.
• Year by year, Other Non-Current Assets stood at $46385.0 in 2021, then surged by 234.91% to $155346.0 in 2022, then soared by 36.47% to $212000.0 in 2023, then surged by 81.6% to $385000.0 in 2024, then soared by 368.83% to $1.8 million in 2025.
• Per Business Quant, the three latest CRBP Other Non-Current Assets figures stand at $1.8 million (Q4 2025), $385000.0 (Q3 2025), and $385000.0 (Q2 2025).